A tweet and a chart to think about.
Was traveling in midwest y'day to see ISI clients. Huge generalist interest in biotech & pharma right now. I mean off the charts.Mark Schoenebaum (@MarkSchoenebaum) February 20, 2014
The New Brunswick, N.J.-based company noted that its pharma sales dipped due to weakness in the U.S. compared to other markets.
Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.